Latest Prostatype Genomics News & Updates

See the latest news and media coverage for Prostatype Genomics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Prostatype Genomics

Developer, manufacturer, and marketer of prognostic prostate cancer genetic tests

prostatypegenomics.com
Headquarters
Stockholm, Sweden
Founded year
2007
Company type
Public company
Number of employees
5–10
Industry
Biotechnology & Medical Research

Last updated

Latest news about Prostatype Genomics

In short: Prostatype Genomics advanced its U.S. market entry, progressed Medicare reimbursement, and raised capital through several rights issues.

Company announcements

Prostatype Genomics

Prostatype Genomics reports US market progress and study findings

CEO Fredrik Persson answers investor questions on CLIA license, Medicare reimbursement, and market potential, while a researcher discusses Prostatype's predictive accuracy in a 25-year study.

Unlock all announcements with a

Media coverage

RTTNews

Prostatype Genomics AB H1 Loss Declines

Prostatype Genomics AB ( PROGEN.ST) announced Loss for first half of -SEK17.32 million The company's earnings totaled -SEK17.32 million, or -SEK0.29 per share. This compares...

Affärsvärlden

Five flags in Prostatype's new issue

The medical technology company Prostatype Genomics is conducting a rights issue that could bring the company 47 million kronor before costs. Emissionsguiden raises five flags.

FinanzNachrichten.de

Prostatype Genomics AB: Prostatype Genomics publishes year-end report for 2025

Prostatype Genomics AB today publishes its year-end report for the full year 2025, including the interim report for the second half of 2025. The full...

Unlock all articles with a

Never miss news about Prostatype Genomics

Track Prostatype Genomics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Prostatype Genomics competitors & trending companies

Browse news for competitors to Prostatype Genomics and other trending companies.